https://www.selleckchem.com/pr....oducts/sovleplenib-h
People with autoimmune or inflammatory conditions who take immunomodulatory/suppressive medications may have a higher risk of novel coronavirus disease 2019 (COVID-19). Chronic disease care has also changed for many patients, with uncertain downstream consequences. Assess whether COVID-19 risk is higher among those on immunomodulating or suppressive agents and characterize pandemic-associated changes to care. Longitudinal registry study. 4666 individuals with autoimmune or inflammatory conditions followed by specialists in
Like
Comment
Share
